共 152 条
[1]
Gibofsky A(2014)Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis Am J Manag Care 20 S128-S135
[2]
Aletaha D(2010)2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Arthritis Rheum 62 2569-2581
[3]
Neogi T(2017)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update Ann Rheum Dis 76 960-977
[4]
Silman AJ(2012)The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review Rheumatology (Oxford) 51 2252-2261
[5]
Funovits J(2019)BSRBR-RA Contributors Group. Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients Rheumatology (Oxford) 58 2162-69
[6]
Felson DT(2016)Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme BMJ Open 6 e010352-3072
[7]
Bingham CO(2008)Real-world physician and patient behaviour across countries: disease-specific programmes—a means to understand Curr Med Res Opin 24 3063-380
[8]
Smolen JS(2016)Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015 Diabetes Metab Syndr Obes 9 371-v37
[9]
Landewé R(2012)Biologic monotherapy as initial treatment in patients with early rheumatoid arthritis Rheumatology (Oxford) 51 v31-1904
[10]
Bijlsma J(2016)Prevalence of biologics monotherapy in a cohort of patients with rheumatoid arthritis in daily clinical practice BMC Musculoskelet Disord 17 110-139